Mercia Pharma

Vaccine in combination with adjuvants for autoimmune, CNS, respiratory and infectious diseases

placeNew York City, New York, United States calendar_todayFounded 2004 language merciapharma.com

Innovation

6 patent families (3 granted) — focus: Human necessities; filing pace steady. Cited 350 times.

YearFilings
20121
20141
20161
20191
20202
20211
20221
20231
20252
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon